title: New obesity pill: new hopes, old fears.
mesh_terms: D019440:Anti-Obesity Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects; D016642:Bupropion / Q000008:administration & dosage* / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D017277:Drug Approval; D004338:Drug Combinations; D015444:Exercise; D005247:Feeding Behavior; D006801:Humans; D008019:Life Style; D009271:Naltrexone / Q000008:administration & dosage* / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D009765:Obesity / Q000188:drug therapy* / Q000628:therapy; D012640:Seizures / Q000139:chemically induced; D059020:Suicidal Ideation; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019440:Anti-Obesity Agents; D018687:Antidepressive Agents, Second-Generation; D018765:Dopamine Uptake Inhibitors; D004338:Drug Combinations; D009292:Narcotic Antagonists; D016642:Bupropion; D009271:Naltrexone